On August 20, 2026, Palo Alto Networks, Inc.’s Board of Directors approved an Executive Change in Control and Severance Policy for designated participants at Senior Vice President level and above who execute participation agreements, including CEO Nikesh Arora, CFO Dipak Golechha, President William BJ Jenkins, and Chief Product and Technology Officer Lee Klarich. Outside a change-in-control protection period, covered executives generally receive 100% salary severance, 12 months of health benefit severance, and 12 months of time-based equity vesting acceleration. During the change-in-control period, the CEO receives 200% salary and cash incentive severance plus 24 months of health benefits, while other executive officers receive 150% salary and cash incentive severance plus 18 months of health benefits, along with 100% acceleration of unvested equity awards. Payments are subject to a signed separation agreement and release, and Section 280G parachute payments may be reduced to avoid excise taxes if that yields a greater after-tax benefit.
Original SEC Filing Text expand_more
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 20, 2026, the Board of Directors (the Board ) of Palo Alto Networks, Inc. (the Company ), upon the recommendation of the Compensation and People Committee of the Board, approved an Executive Change in Control and Severance Policy (the Policy ). The Policy is designed to provide certain severance benefits to selected participants in connection with the involuntary termination of the participant s employment during a specified change in control protection period, or, in certain cases, outside of a change in control protection period. Company employees with the title of Senior Vice President and above who execute a participation agreement with the Company have been designated as participants in the Policy, including the following executives: Nikesh Arora, the Company s Chairman and Chief Executive Officer (the CEO ), Dipak Golechha, the Company s Chief Financial Officer, William BJ Jenkins, the Company s President, and Lee Klarich, the Company s Chief Product and Technology Officer. Under the terms of the Policy, if an executive s employment is terminated by the Company other than for Cause, death or Disability (each, as defined in the Policy) outside of the period beginning three months prior to a Change in Control (as defined in the Policy) and ending 12 months (or 18 months for the CEO) following a Change in Control (the CIC Period ), then, subject to the executive s timely execution and non-revocation of a separation agreement and release of claims with the Company, the executive will receive: (i) salary severance equal to a percentage (as described in the table below) of the executive s base salary ( Salary Severance ); (ii) cash incentive severance equal to the sum of (a) the executive s annual target cash incentive compensation opportunity, prorated based on the number of days elapsed in the fiscal year prior to the date of termination, minus the amount of any actual cash incentive award paid to the executive for a semi-annual performance period that occurs during such fiscal year and (b) to the extent the cash incentive award for the prior fiscal year has not been paid as of the date of termination of employment, 100% of the executive s annual target cash incentive compensation opportunity for such prior fiscal year minus the amount of any actual cash incentive award paid to the executive for a semi-annual performance period that occurs during such fiscal year; (iii) health benefit severance equal to a number of months (as described in the table below) multiplied by the monthly COBRA premium required to continue group health, dental and vision coverage for the executive and their eligible dependents ( Health Benefit Severance ); and (iv) vesting acceleration for any time-based equity awards that otherwise would have vested for the specified number of months (as described in the table below) had the executive remained employed with the Company during such period, with equity awards subject to performance-based vesting conditions remaining outstanding and vesting, as to the portion of the award that otherwise would have vested had the executive remained employed with the Company during such period, based on actual achievement of the performance criteria upon the completion of the applicable performance period. Participant Salary Severance Health Benefit Severance Equity Acceleration Executive Officers (including CEO) 100% 12 months 12 months If an executive s employment is terminated by the Company other than for Cause, death or Disability, or by the executive for Good Reason (as defined in the Policy) during the CIC Period, then subject to the executive s timely execution and non-revocation of a separation agreement and release of claims with the Company, the executive will receive: (i) Salary Severance (based on the percentage described in the table below); (ii) cash incentive severance equal to a percentage (as described in the table below) of the executive s annual target cash incentive compensation opportunity ( Cash Incentive Severance ); (iii) Health Benefit Severance (based on a number of months described in the table below); and (iv) vesting acceleration as to 100% of any equity awards that are outstanding and unvested, provided that the treatment of the performance conditions of awards that are subject to performance-based vesting conditions will be as set forth in the individual award agreement. Participant Salary Severance Cash Incentive Severance Health Benefit Severance CEO 200% 200% 24 months Other Executive Officers 150% 150% 18 months If any payment or benefit payable to a participant constitutes a parachute payment under Section 280G of the U.S. tax code and would be subject to the applicable excise tax, then the participant s payments or benefits will be either (i) delivered in full or (ii) delivered to such lesser extent which would result in no portion of such benefits being subject to the excise tax, whichever results in the receipt by the participant on an after-tax basis of the greatest amount of benefits. The foregoing description of the Policy does not purport to be complete and is qualified in its entirety by reference to the full text of the Policy, which is filed herewith as Exhibit 10.1 to this Current Report on Form 8-K, and is incorporated herein by reference.
